Epizyme

@EpizymeRx

Epizyme is a late-stage biopharma company harnessing the promise of to rewrite therapy for cancer and other serious diseases.

Cambridge, MA
Vrijeme pridruživanja: kolovoz 2012.

Tweetovi

Blokirali ste korisnika/cu @EpizymeRx

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EpizymeRx

  1. 4. velj

    Today and every day, we stand with those diagnosed with . Your resilience in the face of a devastating diagnosis motivates us as we aim to rewrite treatment for cancer.

    Poništi
  2. 29. sij

    that over 300 million people worldwide are living with a ? is next month on Feb. 29. Join the conversation to raise awareness and show solidarity with those living with rare diseases.

    Poništi
  3. 23. sij

    : grants accelerated approval to $EPZM’s first product. Read more:

    Poništi
  4. 21. sij

    As we begin a new year, our vision to rewrite treatment for and other serious diseases remains unchanged. Read more about our Vision here:

    Poništi
  5. 6. sij
    Poništi
  6. 1. sij

    Happy New Year from Epizyme! Our New Year's resolution is to achieve our goals set forth in our Vision 2020. What's yours?

    Poništi
  7. 20. pro 2019.

    Our is ready to relax and spend time with family and loved ones for the winter holidays. We're wishing everyone happy holidays, and we'll see you in the New Year!

    Poništi
  8. 18. pro 2019.

    Today announced the submission of its second New Drug Application to the US FDA. Read the announcement:

    Poništi
  9. 18. pro 2019.

    Epizyme Announces Unanimous Positive Vote (11-0) from the FDA Oncology Drug Advisory Committee. Read today’s news:

    Poništi
  10. 18. pro 2019.
    Poništi
  11. 11. pro 2019.

    A studies biopsies (a small sample of tissue) in a lab & plays a critical role in diagnosing . You might never meet your pathologist, but they play an important role in your care.

    Poništi
  12. 7. pro 2019.

    Today we announced updated data at . Read more:

    Poništi
  13. 6. pro 2019.

    Our is Orlando-bound! If you'll be at , come visit us at booth #769.

    Poništi
  14. 2. pro 2019.
    Poništi
  15. 28. stu 2019.

    Eating, spending time with family, and maybe watching a little football are all just a few reasons our Epizymers love Thanksgiving. We hope you have a relaxing holiday with the ones you love. Happy Thanksgiving from all of us at Epizyme!

    Poništi
  16. 26. stu 2019.

    . defines a as one that occurs in fewer than 15 people per 100,000. is rare, with approx. 150-200 people diagnosed with ES in the U.S. per year. (For those who took our quiz: the answer was B!)

    Prikaži ovu nit
    Poništi
  17. 22. stu 2019.

    Quiz time! is a , but do you know how many diagnoses (per 100,000 people) designate a cancer as rare?

    Prikaži ovu nit
    Poništi
  18. 15. stu 2019.

    This week, we're joining other specialists and researchers from around the world in Tokyo at the Annual Meeting.

    Poništi
  19. 12. stu 2019.

    Receiving an accurate is the first step in addressing . Because ES is ultra-rare, it can be difficult to diagnose. Learn more:

    Poništi
  20. 8. stu 2019.

    A diagnosis of epithelioid sarcoma can be overwhelming. One helpful resource for your patients that can organize their thoughts and start the conversation is the Medical Appointment Discussion Guide, available here:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·